Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-01-04 @ 9:08 PM
Study NCT ID:
NCT07003568
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2025-05-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
Sponsor:
Beijing GoBroad Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsed or Refractory Multiple Myeloma (RRMM) | View |
Keywords: